Skip to content

Effect of grihadhoomadi ointment and dineshavalyadi taila in superficial fungal dermatophytosis in children.

Randomized comparative clinical study to evaluate the efficacy of grihadhoomadi ointment and dineshavalyadi taila in pama with special reference to superficial fungal dermatophytosis in children. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071244
Enrollment
30
Registered
2024-07-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Dr Suryana Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Children in between the age group of 5 years to 10 years irrespective of religion, gender, and socio-economic status. -Children having the clinical features of Pama. -Children having the clinical features of Superficial Fungal Dermatophytosis. -Children whose parents are willing to sign the written consent form and follow the protocol.

Exclusion criteria

Exclusion criteria: -Chronic Superficial Fungal Dermatophytosis (more than 1 year duration). -Superficial Fungal Dermatophytosis associated with secondary infection and lichenification. -Children presenting with Invasive Fungal Dermatophytosis like Aspergillosis, Invasive Candidiasis, etc. -Children presenting with other infectious skin diseases like Leprosy, Skin Tuberculosis, etc. -Other overlapping dermatological diseases like Atopic Dermatitis, Psoriasis, Scabies.

Design outcomes

Primary

MeasureTime frame
Significant decrease in Superficial Fungal Dermatophytosis and Pama assessed based on Dermatophytosis Severity Score and Pama Lakshanas respectively. Timepoint: 0th day - Before treatment 14th day - after treatment 21st day - follow up

Secondary

MeasureTime frame
Generation of in- depth analysed data on different aspects of the disease. Generation of data on possible unexpected drug reaction.Timepoint: 0th day - Before treatment 14th day - after treatment 21st day - follow up

Countries

India

Contacts

Public ContactDr Divyasri RA

Sri Sri College of Ayurvedic Science and Research Hospital

drsuryanagupta@gmail.com08825099050

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026